An inflated stock price has been achievable for CTUM in the past. Maintaining that price after the weeks pass with no news of revenues, approvals, etc IS the problem.
I'm in accord with the group that sees FDA approval as the biggest, oiliest pump the company can wield. As a long term holder, I don't want a single dime to be spent pumping the PPS until approval happens.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.